Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bretylium tosilate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bretylate 100mg/2ml solution for injection ampoules
0203020E0BBAAAA
|
Bretylate | Bretylium tosilate | Cardiovascular System | No data available |
|
Bretylate 500mg/10ml solution for injection ampoules
0203020E0BBABAC
|
Bretylate | Bretylium tosilate | Cardiovascular System | No data available |
|
Bretylium tosilate 100mg/2ml solution for injection ampoules
0203020E0AAAAAA
|
Bretylium tosilate | Bretylium tosilate | Cardiovascular System | No data available |
|
Bretylium tosilate 500mg/10ml inj ampoules
0203020E0AAACAC
|
Bretylium tosilate | Bretylium tosilate | Cardiovascular System | No data available |
|
Bretylium tosilate 500mg/10ml inj Minijet pfs
0203020E0BCAAAB
|
Minjet bretylium tosilate | Bretylium tosilate | Cardiovascular System | No data available |
|
Bretylium tosilate 500mg/10ml inj pre-filled syringes
0203020E0AAABAB
|
Bretylium tosilate | Bretylium tosilate | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.